SCHEMBL22868096

SCHEMBL22868096

CCCC(CC(=O)O)Sc1cccc(C)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 1/20 0.43
TAS1R1 Q7RTX1 1/20 0.43
ALOX5 P09917 1/20 0.40
PPARG P37231 1/20 0.40
PPARA Q07869 1/20 0.40
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
SLC6A3 Q01959 1/20 0.39
FFAR1 O14842 1/20 0.37
ITGB3 P05106 2/20 0.37
ITGAV P06756 2/20 0.37
ITGA2B P08514 2/20 0.37
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PTGER1 P34995 1/20 0.36
PTGFR P43088 1/20 0.36
CTSA P10619 1/20 0.35
CYP26A1 O43174 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4562510 0.75 MEN1 (0.45) ALOX5PPARGPPARASLC6A2SLC6A3
M-Xylene SCHEMBL28029951 0.74 TAS1R3 (0.48) TAS1R3TAS1R1SLC6A2SLC6A4SLC6A3
SCHEMBL22867763 0.72 FFAR1 (0.45) TAS1R3TAS1R1SLC6A2SLC6A4SLC6A3
SCHEMBL6960077 0.72 KIF11 (0.40) ALOX5PPARGPPARASMN1; SMN2LMNA
SCHEMBL9109127 0.71 ALOX5 (0.48) ALOX5PPARGPPARAALDH1A1MAPT
SCHEMBL11599874 0.70 LMNA (0.41) ALOX5PPARGPPARAMAPTSMN1; SMN2
SCHEMBL7376137 0.70 ALDH1A1 (0.44) ALOX5PPARGPPARAALDH1A1MAPT
SCHEMBL9738451 0.70 HPGD (0.37) TAS1R3TAS1R1SLC6A2SLC6A4SLC6A3
SCHEMBL4562509 0.70 TAS1R3 (0.40) TAS1R3TAS1R1FFAR1ITGB3ITGAV
SCHEMBL27804817 0.69 SMN1; SMN2 (0.40) ALOX5PPARGPPARAFFAR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021003295-A1 MODULATORS OF HSD17B13 AND METHODS OF USE THEREOF REGENERON PHARMACEUTICALS, INC. (US) 2021-01-07 WO disclosed